These benefits, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 support the thought of focusing on ACKR3 as a unique technique to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar disorders. Researchers feel that blocking https://stephenw824hez4.blogpixi.com/profile